| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/30/1998 | WO1998017792A1 Binding molecules and computer-based methods of increasing the binding affinity thereof |
| 04/30/1998 | WO1998017791A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 04/30/1998 | WO1998017789A1 Sterol glycosyl transferases |
| 04/30/1998 | WO1998017788A1 Novel secondary alcohol dehydrogenase, process for preparing said enzyme, and process for preparing alcohols and ketones using said enzyme |
| 04/30/1998 | WO1998017783A1 Improved adenovirus vectors |
| 04/30/1998 | WO1998017782A1 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
| 04/30/1998 | WO1998017779A1 NOVEL FabH |
| 04/30/1998 | WO1998017693A1 Composition containing chitosan |
| 04/30/1998 | WO1998017691A1 Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use |
| 04/30/1998 | WO1998017690A1 Receptor specific brain natriuretic peptide (bnp) |
| 04/30/1998 | WO1998017689A2 Il-12 gene expression and delivery systems and uses |
| 04/30/1998 | WO1998017687A2 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | WO1998017685A1 Novel lanthionine antibiotic compositions and methods |
| 04/30/1998 | WO1998017323A1 Improved vaccines |
| 04/30/1998 | WO1998017320A1 Use of hyaluronan in gene therapy |
| 04/30/1998 | WO1998017317A2 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
| 04/30/1998 | WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 04/30/1998 | WO1998017309A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 04/30/1998 | WO1998017308A1 Inhibiting hiv infection by cleaving co-receptor rna |
| 04/30/1998 | WO1998017300A1 Mucin-mediated immunomodulation |
| 04/30/1998 | WO1998017116A1 Targeted cytotoxic cells |
| 04/30/1998 | WO1998011225A3 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/30/1998 | WO1998009983A3 Preparation of purified (poly)peptides |
| 04/30/1998 | WO1998006836A3 Expression system derived from the lipase regulation cascade of pseudomonas alcaligenes |
| 04/30/1998 | WO1998005754A3 Packaging cell lines containing expression constructs producing pseudotyped retroviral vectors |
| 04/30/1998 | WO1998004694A3 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | WO1998003643A3 Transgenic animals with mutant human APP or A4CT sequences |
| 04/30/1998 | WO1998002562A3 Chimera gene with several herbicide resistant genes, plant cell and plant resistant to several herbicides |
| 04/30/1998 | WO1998002545A3 Compositions and methods for plant pathogen resistance |
| 04/30/1998 | WO1997048795A3 Compositions and methods for treating specific gene expression-related diseases and disorders in humans |
| 04/30/1998 | DE19746362A1 Production of nucleic acid conjugates |
| 04/30/1998 | DE19644567A1 Mikrobielle Herstellung von Substanzen aus dem aromatischen Stoffwechsel / II Microbial production of substances from aromatic metabolism / II |
| 04/30/1998 | DE19644566A1 Mikrobielle Herstellung von Substanzen aus dem aromatischen Stoffwechsel / I Microbial production of substances from aromatic metabolism / I |
| 04/30/1998 | DE19644501A1 GABA¶A¶-Rezeptoruntereinheit epsilon-verwandtes Protein GABA¶A¶ receptor epsilon subunit-related protein |
| 04/30/1998 | DE19644500A1 AAV-DNA mit Helfervirus-Sequenzen AAV DNA having helper virus sequences |
| 04/30/1998 | DE19644478A1 Blattspezifische Expression von Genen in transgenen Pflanzen Leaf-specific expression of genes in transgenic plants |
| 04/30/1998 | CA2751712A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2745736A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2292847A1 Compositions and methods using eukaryotic rad52 |
| 04/30/1998 | CA2271721A1 Mini-e1a genes and gene products |
| 04/30/1998 | CA2270154A1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 04/30/1998 | CA2269755A1 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | CA2269754A1 Dna vaccines for herpes simplex virus 1 and 2 |
| 04/30/1998 | CA2269656A1 Receptor specific brain natriuretic peptide (bnp) |
| 04/30/1998 | CA2269644A1 Inhibiting hiv infection by cleaving co-receptor rna |
| 04/30/1998 | CA2269507A1 Targeted cytotoxic cells |
| 04/30/1998 | CA2269444A1 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
| 04/30/1998 | CA2269349A1 Mucin-mediated immunomodulation |
| 04/30/1998 | CA2269123A1 Methods for generating and screening novel metabolic pathways |
| 04/30/1998 | CA2269121A1 Production of cartilage tissue using cells isolated from wharton's jelly |
| 04/30/1998 | CA2269100A1 Methods and compositions for delivery and expression of interferon-.alpha. nucleic acids |
| 04/30/1998 | CA2269074A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2269025A1 Pancreatic lipases and/or recombinant colipases and derived polypeptides produced by plants, methods for obtaining them and use thereof |
| 04/30/1998 | CA2268949A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 04/30/1998 | CA2268816A1 Sterol glycosyl transferases |
| 04/30/1998 | CA2268804A1 Composition containing chitosan |
| 04/30/1998 | CA2268791A1 Method for detecting resistant fungal cells in clinical material |
| 04/30/1998 | CA2268752A1 Plasmids encoding immunogenic proteins and intracellular as follows |
| 04/30/1998 | CA2268751A1 Fringe proteins and notch signalling |
| 04/30/1998 | CA2268749A1 Structural and functional conservation of the c. elegans clock gene clk-1 |
| 04/30/1998 | CA2268746A1 Placental-derived prostate growth factors |
| 04/30/1998 | CA2268744A1 Novel lanthionine antibiotic compositions and methods |
| 04/30/1998 | CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | CA2268720A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 04/30/1998 | CA2268476A1 Use of hyaluronan in gene therapy |
| 04/30/1998 | CA2268365A1 Il-12 gene expression and delivery systems and uses |
| 04/30/1998 | CA2268278A1 Methods of reducing the levels of protoporphyrin ix in recombinant hemoglobin preparations |
| 04/30/1998 | CA2268276A1 Gene expression and delivery systems and uses |
| 04/30/1998 | CA2268271A1 Lentiviral vectors |
| 04/30/1998 | CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | CA2268016A1 Human eosinophil-derived basic protein |
| 04/30/1998 | CA2267636A1 Retroviral vectors |
| 04/30/1998 | CA2239766A1 Method for controlling water content of plant |
| 04/29/1998 | EP0838526A1 Human satellite microchromosomes as vectors for gene therapy |
| 04/29/1998 | EP0838525A2 Streptococcus pneumoniae polypeptide greA |
| 04/29/1998 | EP0838524A2 RsbV-1 derived from Staphylococcus |
| 04/29/1998 | EP0838523A2 RsbW-1 derived from Staphylococcus |
| 04/29/1998 | EP0838522A2 Coccidiosis poultry vaccine |
| 04/29/1998 | EP0838520A2 Frozen dough-resistant, practical baker's yeast |
| 04/29/1998 | EP0838150A1 Method for transforming orchidaceous plant using agrobacterium |
| 04/29/1998 | EP0838149A1 Virus-resistant plant expressing 2',5'-oligoadenylic acid synthetase and ribonuclease l originating in animal cells and process for constructing the same |
| 04/29/1998 | EP0838148A2 A method of plant tissue culture and regeneration |
| 04/29/1998 | EP0838025A1 Self-contained device integrating nucleic acid extraction, amplification and detection |
| 04/29/1998 | EP0837952A2 Detection and quantification of human herpesvirus 7 by enzymatic amplification of virus dna |
| 04/29/1998 | EP0837951A1 Antisense inhibition of hepatitis b virus replication |
| 04/29/1998 | EP0837950A1 Primer walking cycle sequencing |
| 04/29/1998 | EP0837945A2 Novel dna sequences and their use for identifying defence-inducing agents in plants |
| 04/29/1998 | EP0837944A2 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene |
| 04/29/1998 | EP0837943A1 In vivo assays for modulators of sterol biosynthesis |
| 04/29/1998 | EP0837942A1 Nucleic acid coding for cmp-n-acetyl-neuraminic acid hydroxylase and its use for the production of modified glycoproteins |
| 04/29/1998 | EP0837941A1 Detection and biodegradation of explosives |
| 04/29/1998 | EP0837940A1 Novel secretion factors for gram-positive microorganisms, genes encoding them and methods of using it |
| 04/29/1998 | EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 04/29/1998 | EP0837938A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 04/29/1998 | EP0837937A1 Rate controller |
| 04/29/1998 | EP0837936A1 New immunoregulatory protein lst-1 |
| 04/29/1998 | EP0837935A1 3' utr of the human prohibitin gene |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837933A1 Optimized minizymes and miniribozymes and uses thereof |